Global Refractive Surgery Devices Market - Industry Trends and Forecast to 2029

TABLE OF CONTENT

TABLE OF CONTENTS
1 INTRODUCTION 29
1.1 OBJECTIVES OF THE STUDY 29
1.2 MARKET DEFINITION 29
1.3 OVERVIEW OF GLOBAL REFRACTIVE SURGERY DEVICES MARKET 29
1.4 LIMITATIONS 31
1.5 MARKETS COVERED 31
2 MARKET SEGMENTATION 33
2.1 MARKETS COVERED 33
2.2 GEOGRAPHICAL SCOPE 34
2.3 YEARS CONSIDERED FOR THE STUDY 35
2.4 CURRENCY AND PRICING 35
2.5 DBMR TRIPOD DATA VALIDATION MODEL 36
2.6 MULTIVARIATE MODELLING 39
2.7 PRODUCT TYPE LIFELINE CURVE 40
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 41
2.9 DBMR MARKET POSITION GRID 42
2.10 MARKET APPLICATION COVERAGE GRID 43
2.11 VENDOR SHARE ANALYSIS 44
2.12 SECONDARY SOURCES 45
2.13 ASSUMPTIONS 45
3 EXECUTIVE SUMMARY 46
4 PREMIUM INSIGHTS 49
4.1 PESTEL'S MODEL 52
4.2 PORTER'S FIVE FORCES MODEL 53
4.3 GLOBAL REFRACTIVE SURGERY DEVICES MARKET: REGULATIONS 54
4.3.1 REGULATION IN THE U.S. 54
4.3.2 REGULATIONS IN EUROPE 55
4.3.3 REGULATIONS IN SINGAPORE 55
4.3.4 REGULATIONS IN AUSTRALIA 56
5 MARKET OVERVIEW 57
5.1 DRIVERS 59
5.1.1 INCREASING TECHNOLOGICAL ADVANCEMENT 59
5.1.2 RISE IN HEALTHCARE EXPENDITURE 59
5.1.3 INCREASE IN POPULATION WITH MACULAR DEGENERATION 59
5.1.4 RISE IN ADOPTION OF MINIMALLY INVASIVE SURGERIES 60
5.2 RESTRAINTS 60
5.2.1 STRINGENT RULES AND REGULATIONS 60
5.2.2 HIGH COST ASSOCIATED WITH REFRACTIVE SURGERY DEVICES 61
5.2.3 SIDE EFFECTS OF SURGERY 61
5.3 OPPORTUNITIES 63
5.3.1 ACHIEVEMENTS IN LASIK SURGERIES 63
5.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS 63
5.3.3 INCREASING GERIATRIC POPULATION 64
5.3.4 EXCESSIVE USAGE OF DIGITAL DEVICES 64
5.4 CHALLENGES 66
5.4.1 DEARTH OF SKILLED PROFESSIONALS 66
5.4.2 LACK OF HEALTHCARE FACILITIES FOR EYE TREATMENT 66
6 COVID-19 IMPACT ON GLOBAL REFRACTIVE SURGERY DEVICES MARKET 67
6.1 IMPACT ON PRICE 67
6.2 IMPACT ON DEMAND 67
6.3 IMPACT ON SUPPLY 68
6.4 STRATEGIC DECISIONS BY MANUFACTURERS 68
6.5 CONCLUSION 69
7 GLOBAL REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE 70
7.1 OVERVIEW 71
7.2 LASER 74
7.2.1 EXCIMER LASERS 75
7.2.2 FEMTOSECOND LASER/ULTRASHORT PULSE LASER 75
7.2.3 OTHERS 76
7.3 PHAKIC INTRAOCULAR LENS (IOL) 76
7.4 ABERROMETERS / WAVEFRONT ABERROMETRY 77
7.5 SURGICAL INSTRUMENTS & ACCESSORIES 77
7.6 REFRACTIVE SURGERY KITS 78
7.7 PUPILLARY DIAMETER METERS 79
7.8 EPIKERATOMES 80
7.9 MICROKERATOMES 81
7.10 THERMOKERATOPLASTY 81
7.11 LIMBAL RELAXING INCISION KITS 82
7.12 OTHERS 83

8 GLOBAL REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY SURGERY TYPE 85
8.1 OVERVIEW 86
8.2 LASIK (LASER IN-SITU KERATOMILEUSIS) 89
8.3 PHOTOREFRACTIVE KERATECTOMY (PRK) 90
8.4 PHAKIC INTRAOCULAR LENSES (IOL) 91
8.5 ASTIGMATIC KERATOTOMY (AK) 92
8.6 AUTOMATED LAMELLAR KERATOPLASTY (ALK) 93
8.7 INTRACORNEAL RING (INTACS) 94
8.8 LASER THERMAL KERATOPLASTY (LTK) 95
8.9 CONDUCTIVE KERATOPLASTY (CK) 96
8.10 RADIAL KERATOTOMY (RK) 97
8.11 OTHERS 98
9 GLOBAL REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY APPLICATION 100
9.1 OVERVIEW 101
9.2 NEARSIGHTEDNESS (MYOPIA) 104
9.3 FARSIGHTEDNESS (HYPEROPIA) 104
9.4 PRESBYOPIA 105
9.5 ASTIGMATISM 106
10 GLOBAL REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY END USER 108
10.1 OVERVIEW 109
10.2 HOSPITAL 112
10.3 SPECIALTY CLINICS 112
10.4 AMBULATORY SURGICAL CENTERS 113
10.5 OTHERS 114
11 GLOBAL REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY DISTRIBUTION CHANNEL 115
11.1 OVERVIEW 116
11.2 DIRECT TENDER 119
11.3 THIRD PARTY DISTRIBUTORS 119
11.4 OTHERS 120

12 GLOBAL REFRACTIVE SURGERY DEVICES MARKET, BY REGION 122
12.1 OVERVIEW 123
12.2 NORTH AMERICA 128
12.2.1 U.S. 137
12.2.2 CANADA 140
12.2.3 MEXICO 143
12.3 EUROPE 145
12.3.1 GERMANY 154
12.3.2 FRANCE 157
12.3.3 U.K. 160
12.3.4 ITALY 163
12.3.5 SPAIN 166
12.3.6 NETHERLANDS 169
12.3.7 RUSSIA 172
12.3.8 SWITZERLAND 175
12.3.9 BELGIUM 178
12.3.10 TURKEY 181
12.3.11 AUSTRIA 184
12.3.12 NORWAY 187
12.3.13 HUNGARY 190
12.3.14 LITHUANIA 193
12.3.15 IRELAND 196
12.3.16 POLAND 199
12.3.17 REST OF EUROPE 202
12.4 ASIA-PACIFIC 203
12.4.1 CHINA 212
12.4.2 JAPAN 215
12.4.3 INDIA 218
12.4.4 SOUTH KOREA 221
12.4.5 AUSTRALIA 224
12.4.6 SINGAPORE 227
12.4.7 THAILAND 230
12.4.8 MALAYSIA 233
12.4.9 INDONESIA 236
12.4.10 PHILIPPINES 239
12.4.11 VIETNAM 242
12.4.12 REST OF ASIA-PACIFIC 245

12.5 SOUTH AMERICA 246
12.5.1 BRAZIL 253
12.5.2 ARGENTINA 256
12.5.3 PERU 259
12.5.4 REST OF SOUTH AMERICA 262
12.6 MIDDLE EAST AND AFRICA 263
12.6.1 SOUTH AFRICA 270
12.6.2 SAUDI ARABIA 273
12.6.3 U.A.E. 276
12.6.4 EGYPT 279
12.6.5 ISRAEL 282
12.6.6 KUWAIT 285
12.6.7 REST OF MIDDLE EAST AND AFRICA 288
13 GLOBAL REFRACTIVE SURGERY DEVICES MARKET: COMPANY LANDSCAPE 289
13.1 COMPANY SHARE ANALYSIS: GLOBAL 289
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 290
13.3 COMPANY SHARE ANALYSIS: EUROPE 291
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 292
14 SWOT ANALYSIS 293
15 COMPANY PROFILE 294
15.1 JOHNSON AND JOHNSON SERVICES, INC. 294
15.1.1 COMPANY SNAPSHOT 294
15.1.2 REVENUE ANALYSIS 294
15.1.3 COMPANY SHARE ANALYSIS 295
15.1.4 PRODUCT PORTFOLIO 296
15.1.5 RECENT DEVELOPMENT 296
15.1.5.1 PRODUCT LAUNCH 296
15.2 ALCON INC. 297
15.2.1 COMPANY SNAPSHOT 297
15.2.2 REVENUE ANALYSIS 298
15.2.3 COMPANY SHARE ANALYSIS 298
15.2.4 PRODUCT PORTFOLIO 299
15.2.5 RECENT DEVELOPMENTS 299
15.2.5.1 ACQUISITION 299
15.2.5.2 PRODUCT LAUNCH 300

15.3 STAAR SURGICAL 301
15.3.1 COMPANY SNAPSHOT 301
15.3.2 REVENUE ANALYSIS 301
15.3.3 COMPANY SHARE ANALYSIS 302
15.3.4 PRODUCT PORTFOLIO 302
15.3.5 RECENT DEVELOPMENTS 303
15.4 BAUSCH + LOMB INCORPORATED 304
15.4.1 COMPANY SNAPSHOT 304
15.4.2 REVENUE ANALYSIS 304
15.4.3 COMPANY SHARE ANALYSIS 305
15.4.4 PRODUCT PORTFOLIO 305
15.4.5 RECENT DEVELOPMENT 306
15.4.5.1 ACQUISITION 306
15.4.5.2 CE APPROVAL 306
15.5 TOPCON CANADA INC., (A SUBSIDIARY OF TOPCON CORPORATION) 307
15.5.1 COMPANY SNAPSHOT 307
15.5.2 REVENUE ANALYSIS 307
15.5.3 COMPANY SHARE ANALYSIS 308
15.5.4 PRODUCT PORTFOLIO 308
15.5.5 RECENT DEVELOPMENTS 309
15.5.5.1 PARTNERSHIP 309
15.5.5.2 ACQUISITION 310
15.6 AAREN SCIENTIFIC INC. 311
15.6.1 COMPANY SNAPSHOT 311
15.6.2 PRODUCT PORTFOLIO 312
15.6.3 RECENT DEVELOPMENT 312
15.7 AMPLITUDE LASER 313
15.7.1 COMPANY SNAPSHOT 313
15.7.2 PRODUCT PORTFOLIO 313
15.7.3 RECENT DEVELOPMENTS 313
15.7.3.1 PARTNERSHIP 314
15.8 BD 316
15.8.1 COMPANY SNAPSHOT 316
15.8.2 REVENUE ANALYSIS 316
15.8.3 PRODUCT PORTFOLIO 317
15.8.4 RECENT DEVELOPMENTS 317
15.8.4.1 CONFERENCE 317
15.8.4.2 PRODUCT LAUNCH 317

15.9 GLAUKOS CORPORATION 318
15.9.1 COMPANY SNAPSHOT 318
15.9.2 REVENUE ANALYSIS 318
15.9.3 PRODUCT PORTFOLIO 319
15.9.4 RECENT DEVELOPMENTS 319
15.9.4.1 PRODUCT LAUNCH 319
15.9.4.2 ACQUISITION 320
15.10 HOYA SURGICAL OPTICS 321
15.10.1 COMPANY SNAPSHOT 321
15.10.2 PRODUCT PORTFOLIO 321
15.10.3 RECENT DEVELOPMENT 322
15.10.3.1 CONFERENCE 322
15.11 IVIS TECHNOLOGIES 323
15.11.1 COMPANY SNAPSHOT 323
15.11.2 PRODUCT PORTFOLIO 323
15.11.3 RECENT DEVELOPMENTS 324
15.12 LENSAR INC. (A SUBSDIARY OF PDL BIOPHARMA, INC.) 325
15.12.1 COMPANY SNAPSHOT 325
15.12.2 PRODUCT PORTFOLIO 325
15.12.3 RECENT DEVELOPMENTS 325
15.13 MORIA 326
15.13.1 COMPANY SNAPSHOT 326
15.13.2 PRODUCT PORTFOLIO 327
15.13.3 RECENT DEVELOPMENT 327
15.14 NIDEK CO., LTD 328
15.14.1 COMPANY SNAPSHOT 328
15.14.2 PRODUCT PORTFOLIO 328
15.14.3 RECENT DEVELOPMENT 328
15.14.3.1 WEBSITE LAUNCH 328
15.15 OPHTEC BV 329
15.15.1 COMPANY SNAPSHOT 329
15.15.2 PRODUCT PORTFOLIO 329
15.15.3 RECENT DEVELOPMENT 330
15.15.3.1 PRODUCT LAUNCH 330
15.16 RAYNER INTRAOCULAR LENSES LIMITED 331
15.16.1 COMPANY SNAPSHOT 331
15.16.2 PRODUCT PORTFOLIO 331
15.16.3 RECENT DEVELOPMENTS 331
15.16.3.1 NEW DISTRIBUTION UNIT 331
15.16.3.2 ACQUISITION 332
15.16.3.3 ACQUISITION 332
15.17 REICHERT, INC. 333
15.17.1 COMPANY SNAPSHOT 333
15.17.2 PRODUCT PORTFOLIO 333
15.17.3 RECENT DEVELOPMENT 333
15.17.3.1 CONFERENCE 333
15.18 ROWIAK GMBH 334
15.18.1 COMPANY SNAPSHOT 334
15.18.2 PRODUCT PORTFOLIO 334
15.18.3 RECENT DEVELOPMENT 334
15.18.3.1 R&D FACILITY 334
15.19 SCHWIND EYE-TECH-SOLUTIONS 335
15.19.1 COMPANY SNAPSHOT 335
15.19.2 PRODUCT PORTFOLIO 335
15.19.3 RECENT DEVELOPMENTS 336
15.20 TRACEY TECHNOLOGIES 337
15.20.1 COMPANY SNAPSHOT 337
15.20.2 PRODUCT PORTFOLIO 337
15.20.3 RECENT DEVELOPMENT 337
15.20.3.1 R&D FACILITY 337
15.21 ZIEMER OPHTHALMIC SYSTEMS 338
15.21.1 COMPANY SNAPSHOT 338
15.21.2 PRODUCT PORTFOLIO 338
15.21.3 RECENT DEVELOPMENT 338
15.21.3.1 AGREEMENT 339
16 QUESTIONNAIRE 340
17 RELATED REPORTS 344